Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Shenoy P, Maggioncalda A, Malik N, Flowers CR. Incidence patterns and outcomes for Hodgkin lymphoma patients in the United States. Adv Hematol. 2011;2011:725219.
2. Behringer K, Diehl V. Twenty-five years clinical trials of the German Hodgkin Study Group (GHSG). Eur J Haematol. 2005;75:21–5.
3. Koontz BF, Kirkpatrick JP, Clough RW, Prosnitz RG, Gockerman JP, Moore JO, et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin’s disease: cure balanced against complications. J Clin Oncol. 2006;24:605–11.
4. Santoro A, Bonadonna G, Valagussa P, Zucali R, Viviani S, Villani F, et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin’s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol. 1987;5:27–37.
5. 5-year age-standardised relative survival (%), Males and Females. In: International Agency for Research on Cancer, NORDCAN. World Health Organization. 2023. https://nordcan.iarc.fr/en/dataviz/survival?cancers=370&sexes=1_2. Accessed 9 June 2023.